Pharmaceutical groups rarely operate as a single entity in a single country. Manufacturing may sit in one company, distribution in another, and procurement or sales may span multiple currencies. Within SigzenPHARMA, ERPNext multi-currency and multi-company support lets a group run several legal entities under one ERPNext Pharma instance while transacting in the currencies each market requires. This matters because pharmaceutical operations import APIs and excipients from overseas suppliers, export finished products to regulated markets, and must keep each entity's records, accounts, and approvals properly separated. The feature is used by Finance, Procurement, Warehouse, and Regulatory teams whenever transactions cross company or currency boundaries. By managing each entity through its own Company master while preserving consolidated visibility, ERPNext Pharma supports accurate financial records, controlled access between entities, and the traceability needed for audit readiness across a multi-entity pharmaceutical group.
Managing Multiple Entities Within ERPNext Pharma
In ERPNext Pharma, each legal entity is set up as a separate Company master, giving it its own chart of accounts, cost centers, warehouses, and default currency. ERPNext multi-company setup allows an Indian manufacturing company and a UK distribution company, for example, to operate under one system while keeping their books and records distinct.
Users interact with the entities through the company selector and company-scoped documents. A Finance user posting an invoice, or a Warehouse user creating a stock entry, does so against a specific company, so transactions are always attributed to the correct legal entity. This separation keeps each entity inspection-ready in its own right, while group management retains a single platform for oversight.
- Company-Specific Records Each company holds its own accounts, warehouses, and transactions, keeping financial and inventory data properly segregated.
- Shared Master Data Where Appropriate Item masters, suppliers, and customers can be shared or restricted per company, avoiding duplicate setup while maintaining control.
- Independent Compliance Posture Because each entity's records stand alone, an audit of one company draws on that company's own controlled data.
Handling Foreign-Currency Procurement and Sales
Pharmaceutical supply chains routinely cross currencies, and ERPNext Pharma records each transaction in its actual currency. Multi-currency transactions let a Purchase Order to a European API supplier be raised in EUR while the buying company's books are maintained in INR.
When Procurement creates that Purchase Order, ERPNext Pharma captures the supplier's currency and applies the relevant exchange rate, then records both the transaction-currency value and the company-currency equivalent. The same applies to foreign currency procurement of excipients or packaging, and to export sales a finished-product invoice to a customer in an export market can be issued in that market's currency while the entity's accounts remain in its base currency.
This dual-currency recording means Procurement and Finance work in the currency that is operationally correct, while the company's financial statements stay consistent in the base currency, with the exchange basis documented on each transaction.
Currency Exchange Rates and Revaluation
Accurate valuation depends on controlled exchange rates, which ERPNext Pharma manages through Currency Exchange records. Currency exchange rate management lets Finance maintain rates that transactions draw on, so conversions are consistent and traceable rather than entered ad hoc.
How Users Manage Rates
- Maintained Exchange Rates Finance records exchange rates in ERPNext Pharma, which purchase, sales, and payment documents reference automatically.
- Documented Conversion Basis Each foreign-currency document stores the rate applied, so the conversion behind any figure can be traced during review.
- Period-End Revaluation Outstanding foreign-currency balances can be revalued so financial statements reflect current rates at period close.
Because every rate and conversion is stored against the underlying record, the financial trail is defensible when a figure is questioned during an audit.
Inter-Company Transactions Between Group Entities
Pharmaceutical groups frequently move goods and services between their own entities — a manufacturing company supplying a distribution company, for instance. ERPNext Pharma handles these through inter-company transactions, where a sale from one group company generates the corresponding purchase in the other.
When the manufacturing entity issues an inter-company sales order for finished product to the group's distribution entity, ERPNext Pharma can create the matching purchase document in the receiving company, keeping both sets of books aligned. This reduces duplicate entry and keeps the two entities' records consistent, while each transaction remains attributed to its own company for accounting and traceability. For a group shipping product batches between entities, this keeps the commercial record aligned with the physical movement tracked in Batch Management.
Consolidated Reporting and Company-Level Access Control
Running multiple entities requires both consolidated oversight and strict separation, and ERPNext Pharma provides both.
- Consolidated Financial Reporting ERPNext Pharma's consolidated financial statement reporting brings group entities together into a combined view, supporting consolidated financial reporting for management and statutory purposes.
- Company-Level Access Control Through user permissions and role-based access control, company-level access control restricts each user to the entities they are authorized for, so a distribution-company user does not see or post against the manufacturing company.
- Dashboards Per Entity Company-scoped dashboards and reports let each team monitor its own entity's position while group finance retains the consolidated picture.
This combination keeps sensitive financial and operational data properly segregated while giving leadership a single, consistent group view.
Audit Trail and Traceability Across Entities
Every financial and inventory document across companies carries ERPNext Pharma's audit trail, recording who created or amended it, when, and in which company. Because transactions are attributed to a specific company and currency, and every exchange rate and inter-company link is stored, the group can trace any figure back to its origin. This supports audit readiness for each entity individually and for the group as a whole, whether the review is financial, regulatory, or a supply-chain traceability check.
Frequently Asked Questions
How does ERPNext Pharma manage multiple legal entities in one system?
Each entity is configured as a separate Company master in ERPNext Pharma, with its own chart of accounts, cost centers, warehouses, and default currency. Users transact against a selected company, so records stay attributed to the correct entity. Master data such as items and suppliers can be shared or restricted per company. This keeps each entity's books and inventory segregated and independently inspection-ready while running on one platform.
How are foreign-currency purchases and sales recorded?
When Procurement raises a purchase order to an overseas supplier, ERPNext Pharma captures the transaction in the supplier's currency and applies the relevant exchange rate, storing both the transaction-currency value and the company-currency equivalent. Export sales work the same way in the customer's currency. This lets teams work in the operationally correct currency while each entity's financial statements remain consistent in its base currency, with the conversion documented on every document.
How does ERPNext Pharma handle exchange rates?
Finance maintains rates through Currency Exchange records in ERPNext Pharma, which purchase, sales, and payment documents reference automatically, keeping conversions consistent rather than entered manually. Each foreign-currency document stores the rate applied, so the basis behind any figure is traceable. Outstanding foreign-currency balances can be revalued at period end so statements reflect current rates, and every rate is retained for audit review.
What are inter-company transactions and how do they work here?
Inter-company transactions handle movements between group entities for example, a manufacturing company supplying a distribution company. In ERPNext Pharma, an inter-company sales order in one company can generate the matching purchase document in the other, keeping both sets of books aligned and reducing duplicate entry. Each transaction stays attributed to its own company, so the records remain consistent with the physical batch movement and traceable for accounting and audit.
How does ERPNext Pharma keep entities' data separated?
Through user permissions and role-based access control, each user is restricted to the companies they are authorized for, so they cannot view or post against unrelated entities. Documents are company-scoped, and dashboards and reports can be filtered per entity. This segregation protects sensitive financial and operational data across the group while still allowing group finance to access consolidated reporting for oversight.
Can the group see consolidated financials across companies?
Yes. ERPNext Pharma provides consolidated financial statement reporting that combines group entities into a single view for management and statutory purposes, while each company retains its own standalone records. Group finance sees the consolidated position, and individual teams monitor their own entity through company-scoped dashboards. Because consolidation draws on each company's controlled transactions, the combined figures remain traceable to their source.
Which teams use multi-currency and multi-company support?
Finance uses it for accounting, exchange rates, and consolidation; Procurement for foreign-currency purchasing of APIs, excipients, and packaging; Warehouse for company-scoped stock and inter-company movements; and Regulatory or management for entity-level and group oversight. Because all teams work on the same ERPNext Pharma instance with company-level access control, each operates within its authorized entity while the group retains consistent, traceable records.
Conclusion
Multi-currency and multi-company support lets a pharmaceutical group run several legal entities within one ERPNext Pharma instance while transacting in the currencies each market requires. By managing each entity through its own Company master, recording transactions in their actual currency with documented exchange rates, and aligning group entities through inter-company transactions, ERPNext Pharma keeps records accurate and properly segregated. Role-based access control separates entity data, while consolidated financial reporting gives leadership a single group view. Every document carries ERPNext Pharma's audit trail, keeping each entity and the group as a whole traceable and inspection-ready. For Finance, Procurement, Warehouse, and Regulatory teams, the value is controlled, currency-accurate operations across a multi-entity pharmaceutical business.
.png)
.png)